Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - Senseonics Holdings, Inc. | sens-20160510ex991964267.htm |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 10, 2016
SENSEONICS HOLDINGS, INC. |
(Exact Name of Registrant as Specified in its Charter) |
Delaware |
|
001-37717 |
|
47-1210911 |
(State or Other |
|
(Commission File Number) |
|
(IRS Employer |
20451 Seneca Meadows Parkway |
(Address of Principal Executive Office) (Zip Code) |
Registrant's telephone number, including area code: (301) 515-7260
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On May 10, 2016, Senseonics Holdings, Inc. issued a press release announcing that the Eversense® CGM System, the first and only long-term, implantable continuous glucose system for people with diabetes has received CE Mark approval.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K, the contents of which are incorporated herein by reference. The information contained in this Current Report on Form 8-K speaks only as the date hereof. While the Company may elect to update the information in this Current Report on Form 8-K in the future, the Company disclaims any obligation to do so except to the extent required by applicable law.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
NumberDescription
99.1Press release of Senseonics Holdings, Inc. dated May 10, 2016.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 10, 2016 |
SENSEONICS HOLDINGS, INC. |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ R. Don Elsey |
|
Name: |
R. Don Elsey |
|
Title: |
Chief Financial Officer |